Missed the Cancer Moonshot webinar? Read the highlights on FasterCures' blog! | Check out the topics for Partnering for Cures, Nov. 13 to 15 in New York | Biohackers take a crack at drug development
July 26, 2016
FOLLOW FASTERCURES ONLINE  FacebookTwitter
FasterCures SmartBrief
Faster News for FasterCures
SIGN UP ⋅   FORWARD
Top News
Precision Medicine Initiative gears up for enrollment drive
Scientists are collaborating with community health centers to recruit a participant pool for the Precision Medicine Initiative that reflects the nation's geographic, ethnic, racial and socioeconomic diversity. Study leaders hope to recruit 1 million participants, who will be asked to share genetic, medical, environmental exposure and lifestyle data with researchers.
The New York Times (free-article access for SmartBrief readers) (7/23) 
LinkedIn Twitter Facebook Google+ Email
News from FasterCures
Missed the Cancer Moonshot webinar? Read the highlights on FasterCures' blog!
If you missed FasterCures' webinar, "Countdown to a Cure: What's Next for the Cancer Moonshot," you can read the highlights on our blog. Find out why presenters Greg Simon, executive director, Cancer Moonshot Task Force, and Ellen Sigal, chairperson and founder, Friends of Cancer Research, feel the time is right to make tremendous progress toward ending cancer as we know it.
LinkedIn Twitter Facebook Google+ Email
Check out the topics for Partnering for Cures, Nov. 13 to 15 in New York
You can now view the general schedule and topics for this year's Partnering for Cures meeting, which brings together hundreds of decision-makers from across diseases who are motivated by the same mission: To reduce the time and cost of getting new therapies from discovery to patients. More details will be added throughout the summer. Register today.
LinkedIn Twitter Facebook Google+ Email
Learn more about FasterCures:
FasterCures Home | Milken Institute
Science and Technology
Biohackers take a crack at drug development
Volunteers working on the Open Insulin Project are trying to develop new ways to make insulin in an effort to boost worldwide supplies and accessibility, and the data they generate will be openly available. Success is a longshot, says former FDA Center for Drug Evaluation and Research Director Carl Peck, as the so-called biohackers lack the funding needed to bring a new drug to market.
KQED.org (7/25) 
LinkedIn Twitter Facebook Google+ Email
Cancer center tests wearables, apps for patient-generated health data
Memorial Sloan Kettering Cancer Center and Medidata are conducting a study of 40 patients with multiple myeloma that involves using wearable monitors to track participants' activity and sleep patterns, and using apps to conduct quality-of-life surveys. "This is a first exercise and the hope is that we'd be able to take learnings from this exercise to the deployment of mobile health technologies," said Kara Dennis, managing director of mobile health at Medidata.
MobiHealthNews.com (7/21) 
LinkedIn Twitter Facebook Google+ Email
China to launch human trial using CRISPR-edited genes in Aug.
Scientists with Sichuan University's West China Hospital in August will launch a trial of a therapy that uses CRISPR-edited genes in patients with lung cancer previously treated with chemotherapy and radiation. The researchers will collect T cells from three study participants, eliminate a gene from the cells that encodes a protein named PD-1 using CRISPR-Cas9 technology and then reintroduce the modified cells.
Science World Report (7/23) 
LinkedIn Twitter Facebook Google+ Email
Finance and Economics
Rare-disease drug startup attracts investment from Pfizer
Pfizer Venture Investments participated in a $17 million Series A funding round for startup Vtesse, a spinoff from the orphan-drug incubator Cydan Development. The company is developing a compound licensed from NIH for treating Niemann-Pick Type C1 disease.
American City Business Journals/Washington, D.C. (7/25) 
LinkedIn Twitter Facebook Google+ Email
Video game developer gets backing from big drugmakers
Merck and Amgen recently invested through their venture capital arms in Akili Interactive Labs, a startup creating mobile video games designed to diagnose and treat various cognitive disorders. Akili intends to test its clinical-stage products on neurodegenerative diseases, such as Parkinson's disease and multiple sclerosis, to track disease progression and potentially help treat early-stage cases.
Xconomy (7/20) 
LinkedIn Twitter Facebook Google+ Email
San Diego scientist training program receives $5.9M from NIH
The NIH has awarded a $5.9 million grant to the University of California, San Diego, for its postdoctoral research and career development program. The funds will go toward training and supporting 15 young scientists.
Times of San Diego (7/21) 
LinkedIn Twitter Facebook Google+ Email
Society and Ethics
Opinion: Privatization of health data could slow scientific progress
Tech titans including Google, Apple, IBM and Microsoft are gathering, analyzing and storing people's health information, and the digitization of patient data promises to radically improve health care, but that promise will not be met if corporations continue to retain data in closed-loop systems, write Eric Topol and John Wilbanks, a FasterCures senior fellow. "[F]or such data to truly empower patients, customers must be able to easily send the information to their health provider, genetic counselor or any analyst they want," Topol and Wilbanks write.
Nature (free content) (7/20) 
LinkedIn Twitter Facebook Google+ Email
Why has no one been able to replicate the Ice Bucket Challenge?
The ALS Ice Bucket Challenge that encouraged people to dump cold water on their heads to raise money for the ALS Association was a success, raising $220 million worldwide for organizations without seeming to take away from other charitable giving, writes James Surowiecki. The campaign was a successful use of social media to reach younger audiences, but one that no other charity seems able to duplicate.
The New Yorker (tiered subscription model) (7/25) 
LinkedIn Twitter Facebook Google+ Email
Advocacy groups for pediatric diseases grow up
As more patients with pediatric diseases live longer, they are becoming their own advocates, and advocacy groups founded by parents are considering adult issues such as insurance coverage for assisted living, transportation and reproductive services. Some parent-run groups are at odds with patient-run groups as concerns diverge.
The Wall Street Journal (tiered subscription model) (7/25) 
LinkedIn Twitter Facebook Google+ Email
FasterCures is an action tank that works across sectors and diseases to improve the effectiveness and efficiency of the medical research enterprise. FasterCures, a center of the Milken Institute, is nonpartisan and independent of interest groups.
Contact Us
FasterCures
1101 New York Avenue, NW
Suite 620
Washington, DC 20005
(202) 336-8900 | www.fastercures.org
 
Media Inquiries
Karen Rogers
Associate Director, Communications
202.336.8919
krogers@fastercures.org
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information